
Adaptive Biotechnologies (ADPT) Stock Forecast & Price Target
Adaptive Biotechnologies (ADPT) Analyst Ratings
Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 43%
Hold 14%
Sell 7%
Strong Sell 0%
Adaptive Biotechnologies (ADPT) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 43% recommend Buy, 14% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Adaptive Biotechnologies and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Adaptive Biotechnologies and is not a guaranteed prediction by Public.com or investment advice.
Adaptive Biotechnologies (ADPT) Analyst Forecast & Price Prediction
Get the latest Adaptive Biotechnologies (ADPT) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Adaptive Biotechnologies (ADPT)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Adaptive Biotechnologies (ADPT) Forecast
Analysts have given Adaptive Biotechnologies (ADPT) a Buy based on their latest research and market trends.
According to 14 analysts, Adaptive Biotechnologies (ADPT) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $37.71, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $37.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.